Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: An Advanced Echocardiographic Evaluation of Nebivolol [Phase 4]
Phase 4 clinical trial evaluating nebivolol via advanced echocardiographic methods in hypertension; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: The Penn Lifestyle Modification and Blood Pressure Study [NA]
This document notes the completion of the Penn Lifestyle Modification and Blood Pressure Study, a clinical trial evaluating lifestyle change…
-
FDA approval · 2015-11-24FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)
The FDA approved a Cipla USA Inc. supplemental application for Quinapril and Hydrochlorothiazide to add the 10/12.5 dosage strength to the p…
-
FDA approval · 2015-11-24FDA Approved: NIFEDIPINE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for nifedipine by Upsher-Smith Laboratories, LLC, facilitating a labeling/strength update for the ge…
-
FDA approval · 2015-11-24FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril hydrochloride from Aurobindo Pharma Limited, enabling the generic product Quinapril hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Medication Adherence With Polyglot Meducation [NA]
A completed clinical trial evaluated adherence to a polyglot medication regimen in patients with hypertension, diabetes mellitus, and hyperc…
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers [Phase 2]
Phase 2 results report on how LCZ696 (sacubitril/valsartan) affects sodium excretion in patients with hypertension, heart failure, and in he…
-
FDA approval · 2015-11-20FDA Approved: VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for valsartan submitted by Lupin Pharmaceuticals, Inc.
-
FDA approval · 2015-11-20FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Losartan Potassium 25 mg from Strides Pharma Science Limited, granting approval for the generic …
-
FDA approval · 2015-11-20FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure [Phase 2]
A Phase 2 clinical trial update evaluating HFS-guided renal ablation to improve outcomes of renal denervation for hypertension.
-
FDA approval · 2015-11-18FDA Approved: IRBESARTAN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for IRBESARTAN filed by Chartwell RX, LLC under the ANDA umbrella, indicating an approved change…
-
FDA approval · 2015-11-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic combination product lisinopril and hydrochlorothiazide manufactured by Aurobindo Pha…
-
FDA approval · 2015-11-18FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR (azilsartan medoxomil and chlorthalidone) submitted by Azurity Pharmaceuticals (f…
-
FDA approval · 2015-11-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from GSMS, Incorporated.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Tailored Intervention to Improve Medication Adherence in Patients With Hypertension [NA]
A completed clinical trial evaluated a tailored intervention to improve medication adherence in patients with hypertension. The update notes…
-
FDA approval · 2015-11-17FDA Approved: PRAZOSIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prazosin hydrochloride from Mylan Pharmaceuticals Inc., enabling the generic version to be m…
-
FDA approval · 2015-11-17FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for labetalol hydrochloride (Hospira) authorizing continued marketing of the generic product und…
-
FDA approval · 2015-11-17FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for amlodipine besylate and atorvastatin calcium from Dr. Reddy's Laboratories Inc, enabling its mar…
-
FDA approval · 2015-11-17FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for a fixed-dose combination of telmisartan and amlodipine. The …
-
FDA approval · 2015-11-17FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approves a supplemental application for IRBESARTAN submitted by Solco Healthcare U.S., LLC.
-
FDA approval · 2015-11-17FDA Approved: TELMISARTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for telmisartan from Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
A pilot trial evaluating cardiovascular events in high-risk orthopedic surgical patients has been withdrawn.
-
FDA approval · 2015-11-16FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic amlodipine and atorvastatin combination from Mylan Pharmaceuticals Inc., under the AND…
-
FDA approval · 2015-11-13FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for the Telmisartan and Hydrochlorothiazide product from Lupin Pharmaceuticals, Inc., to support its…